RGCB products for Covid-19 management get manufacturing license

RGCB products for Covid-19 management get manufacturing license

Deccan Herald
PTI,

A cost-effective Rapid Antibody Card developed indigenously by the city-based Rajiv Gandhi Centre for Biotechnology (RGCB), is among the three key products that have obtained manufacturing license, lending a cutting edge to Covid-19 management efforts in the country.

The two other products of RGCB, under the central government, which have been granted a license by the Central Drugs Standard Control Organization (CDSO), are Viral Transport Media (VTM) kit and a viral RNA extraction kit.

These products have been developed by RGCB in partnership with Sperogenx Biosciences Pvt Ltd, Bengaluru, and POCT Services, New Delhi, under SARS-CoV-2 diagnostic umbrella.

Disclaimer: This is an automatically aggregated article/story by a computer program and has not been created or edited by Newsdig.in.

World COVID19 Meter

18353581

Cases

11345628

Recovered

694898

Deaths
Last updated: GMT
Advt
Advt
Advt
sitemap Disclaimer
Newsdig.in 2019